Pharmacokinetic/pharmacodynamic modelling to evaluate the efficacy of various dosing regimens of ceftazidime/avibactam in patients with pneumonia caused by Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae: a multicentre study in northern China.
J Glob Antimicrob Resist
; 27: 67-71, 2021 12.
Article
in En
| MEDLINE
| ID: mdl-34428596
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Klebsiella Infections
/
Ceftazidime
/
Pneumonia, Bacterial
/
Azabicyclo Compounds
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Humans
Country/Region as subject:
Asia
Language:
En
Journal:
J Glob Antimicrob Resist
Year:
2021
Document type:
Article
Affiliation country:
China